ChinaBio(R) LLC Release: China Announces Blacklist For Medical Bribery And Substandard Products

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

January 6, 2014 -- China will institute an official blacklisting system of drugmakers and medical device manufacturers to punish them for bribing officials or providing substandard products. The system was announced by the National Health and Family Planning Commission recently. It will prevent a company from selling products in any province for two years where it has been found guilty of an infraction. If the company commits two infractions in a five-year period, it will be banned from selling its products anywhere in China, also for two years. The blacklist will officially begin operations on March 1. More details....

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC